Introduction
This chapter covers natural glycoconjugates in which carbohydrates are covalently linked to amino acids which themselves are part of a peptide or protein.
Three classes of biologically important compounds fulfill this criterion:
-glycoproteins including their substructures, the glycopeptides, -the bacterial cell wall polymer peptidoglycan, and -glycopeptide antibiotics.
Glycoproteins constitute the most diverse of these classes of glycoconjugates. Their substructures, the glycopeptides, occur as natural and artificial degradation products of glycoproteins during metabolism and structural analysis, respectively, or they are obtained synthetically in order to probe their structure and/or function. Peptidoglycan is commonly not regarded as a glycopeptide. It forms a bag-like macromolecule (called the sacculus) wrapping bacteria and thereby contributing essentially to their mechanical stability. However, it is connected with glycopeptides not only by virtue of its composition but also because its biosynthesis is inhibited by (beside β -lactam antibiotics) glycopeptide antibiotics. The latter are secondary metabolites produced in actinomycetes and are dealt with at the end of this chapter.
Glycoproteins
Glycoproteins [1] consist of carbohydrates covalently linked with proteins and are ubiquitous in all forms of life from Archaebacteria to humans although they are rare in eubacteria. Their carbohydrate content is variable from less than 1%, as in some collagens, to over 99%, as in glycogen. The carbohydrate may be in the form of a monosaccharide or disaccharide, but more frequently in the form of oligosaccharides and polysaccharides (up to hundreds of monosaccharides in size), or their derivatives (e.g., sulfo-or phospho-substituted), linear or branched, generally referred to as glycans. The number of glycans present in a glycoprotein differs greatly from a single residue to more than one hundred. The carbohydrate chains are attached to the polypeptide backbone by characteristic carbohydrate-peptide linkages.
Being the most important co-and post-translational modification, glycosylation is found in most proteins including enzymes, antibodies, receptors, hormones, cytokines, and structural proteins. Glycoproteins occur inside cells, both in the cytoplasm and in subcellular organelles, in extracellular fluids as well as embedded in cell membranes. In the latter case the glycans are located extracellularly. Blood serum is an especially rich source of glycoproteins. Of the almost 100 proteins that have been identified in this fluid, almost all are glycosylated. Serum albumin is one of the rare exceptions in this respect although a genetic variant in which it is glycosylated has been discovered recently [2] .
A striking feature of almost all glycoproteins is the polymorphism associated with their glycan moieties, a phenomenon known as microheterogeneity. This type of diversity derives from the fact that glycans are secondary gene products and is manifested in that individual molecules of a given glycoprotein carry different oligosaccharides at the same glycosylation site of the protein backbone. The resulting variants, referred to as glycoforms, were first observed in 1962 by Schmid et al. in α 1 -acid glycoprotein from human serum by electrophoresis [3] . This glycoprotein contains five glycosylation sites modified with di-, tri-, and tetraantennary glycans of the N -acetyllactosamine type [4] . In addition, the glycans can be fucosylated [5] and sialylated at different levels. Microheterogeneity is also observed in proteins with a single glycosylation site like chicken ovalbumin. Close to 20 different oligosaccharides have been identified at that site (Asn-293) [6] . One of the very rare cases in which microheterogeneity is absent is soybean agglutinin (SBA), a plant glycoprotein with a single uniform oligosaccharide per subunit, namely Man 9 (GlcNAc) 2 [7] . This is mainly why SBA is the best source for a preparative isolation of this oligosaccharide. Up to now, many thousands of primary glycan structures have been characterized. Many of them are contained in the Complex Carbohydrate Structure Database (CCSD) which is searchable by the CarbBank program [8] .
The observation of microheterogeneity gives rise to many interesting questions regarding the origin of this phenomenon and its biological relevance. Whereas in the early view the heterogeneity of the glycans was thought to be random and mainly a result of the lack of fidelity in their synthesis, it now appears that, under constant physiological conditions, the populations in a set of glycoforms are reproducible and highly regulated. Moreover, the populations change under certain conditions such as cell growth, cell differentiation, and disease, including malignant transformation, suggesting that the presence of different but defined glycoforms is indeed required for the normal functioning of an organism.
Today we know there is no single unifying function for the carbohydrates present in glycoproteins [9] . Perhaps their major function is to participate in numerous physiological and pathological molecular recognition events. In addition, they may modify the physical, chemical, and biological properties of the proteins to which they are attached. It has been shown that the glycans alter charge and solubility of proteins and influence the conformation and dynamic properties of the polypeptide chain. Due to their large size, the oligosaccharides may cover functionally important areas of the proteins and thus regulate their interactions with other biomolecules or protect the protein from proteolytic degradation. Properties and functions of glycoproteins are covered in Chapt. 8.2 of this book.
[a] Unless otherwise stated, all monosaccharides are of D -configuration and the ring form is pyranose. 
Monosaccharide Constituents
For a long time, less than a dozen monosaccharides were considered to be the main constituents of glycoproteins. Beside these "classical" saccharides, however, refinement of the analytical methods brought up many new monosaccharides during the last 15 years, originally considered as rare but which now appear to be more common than previously thought. Table 1 [1f, 10, 11] gives an overview of the classical and some examples of the rare monosaccharide constituents of glycoproteins.
Carbohydrate-Peptide Linkages
There are three major types of linkages between carbohydrates and proteins [1, 12] :
-N -glycosidic, between the reducing end monosaccharide and the side chain amide group of asparagine ( N -glycans), -O -glycosidic, between the reducing end monosaccharide and the side chain hydroxy group of most commonly serine and threonine but also hydroxyproline and hydroxylysine ( O -glycans), and -via ethanolamine phosphate, between the C-terminal amino acid of the protein and an oligosaccharide attached to phosphatidylinositol, generally known as glycosylphosphatidylinositol (GPI) anchor.
Beside these, a number of uncommon linkages are found in nature including Cglycosides and carbohydrates linked via a phosphodiester bridge. The non-enzymatic condensation of reducing monosaccharides like glucose with the sidechain amino group of lysine leads via initial Schiff bases and subsequent rearrangements to the formation of so-called advanced glycation end products (AGEs). AGEs have been implicated in alterations of proteins during aging and longterm diabetes [13] and are not dealt with in this chapter.
N-Glycosides
Until recently, the only type of N -glycosidic linkage which had been characterized in glycoproteins regardless of their origin was the N -acetylglucosaminyl( β 1-N)asparagine bond discovered by Neuberger et al. [14] and almost simultaneously by others [15, 16] . During biosynthesis the enzyme oligosaccharyl transferase (OT) transfers a triantennary tetradecasaccharide (Glc 3 Man 9 GlcNAc 2 ) from dolichol pyrophosphate to the amide nitrogen of an Asn side chain in the nascent polypeptide. In the subsequent trimming process this oligosaccharide is modified by the action of several glycosylhydrolases and glycosyltransferases resulting in a structural diversity of glycans sharing a com-mon core pentasaccharide (Scheme 1). The primary peptide sequence requirements for OT-catalyzed glycosylation include a minimum Asn-Xaa-Ser/Thr tripeptide recognition motif where Xaa can be any of the 20 natural amino acids except proline. However, it is found that not all such consensus tripeptides (sequons) are glycosylated. A plausible explanation arises from mechanistic studies on the OT-catalyzed glycosylation of linear and constrained model peptides [17] . It could be demonstrated that only peptides which are able to adopt an Asxturn conformation [18] are efficient substrates of OT leading to the proposed mechanism of oligosaccharyl transfer shown in Scheme 2 [19] . In this model, the apparent failure of the glycosylation machinery most likely results from conformational influence by the neighboring polypeptide sequence that may override the potential for the tripeptide acceptor sequence to adopt an Asx-turn and therefore limit its compatibility with the OT active site. However, although necessary, formation of an Asx-turn might not be sufficient [20] . During recent years, linkages between asparagine side chains and other carbohydrates such as α - [21] and β -glucose [22] , β -N -acetylgalactosamine [23] and L -rhamnose [24] have been discovered mainly in bacterial glycoproteins [25] . However, the β -glucosyl-asparagine linkage has also been found in the mammalian protein laminin [26] . Whenever carefully studied, the saccharides In addition, the inner-core may be substituted by several monosaccharides (dashed arrows)
Proposed mechanism of asparagine activation for oligosaccharyl transferase [19] are attached to the sequon Asn-Xaa-Ser/Thr, except for the glycopeptide nephritogenoside in which glucose is α -linked to the amide side chain of the N -terminal tripeptide Asn-Pro-Leu [21] .
O-Glycosides
In contrast to N -glycoproteins, biosynthesis of the glycan chains of O -glycoproteins is an entirely post-translational process and starts with the addition of a single monosaccharide to a hydroxyamino acid of the protein backbone. Therefore, a variety of carbohydrate-protein linkages is found in O -glycoproteins (Scheme 3). The N -acetylgalactosaminyl( α 1-O)serine/threonine linkage (also called Tn antigen) was first demonstrated in mucins and is widely distributed in nature in the so-called mucin-type glycoproteins. Another widely occurring Oglycosidic bond which was discovered only recently is that between β -Nacetylglucosamine and the serine/threonine hydroxy group [27, 28] . This type of attachment is present predominantly in intracellular glycoproteins (nuclear pore, chromatin proteins, transcription factors, and cytoplasmic inclusions). Interestingly, no other sugars are connected to the N -acetylglucosamine residue. In the epidermal growth factor (EGF) modules of several blood coagulation and fibrinolytic proteins L -fucose was characterized to be α -linked to serine or threonine in the consensus sequence Cys-Xaa-Xaa-Gly-Gly-Ser/Thr-Cys [29] . EGF modules also contain glucose β -O -linked to serine within the consensus sequence Cys-Xaa-Ser-Xaa-Pro-Cys, an example being the bovine blood clotting factor IX [30] . α -Galactose bound to serine is found in plant glycoproteins like extensin or potato lectin and in the glycoproteins from the cellulosome, an extracellular complex of cellulases, produced by cellulolytic bacteria [31] . When human insulin-like growth factor-I (IGF-I) was expressed in yeast, a new form of IGF-I was characterized in addition to IGF-I in which mannose is α -glycosidically linked to threonine [32] . The mannosyl-Ser/Thr linkage has also been reported in Ser/Thr-rich domains of the bovine peripheral nerve α -dystroglycan [33] and in rat brain proteoglycans [34, 35] . Xylosyl( β 1-O)serine is found in animal proteoglycans and, at the present, considered to be confined to these glycoproteins.
O -Glycosylation is, however, not limited to serine and threonine. In glycogenin, the priming enzyme for glycogen synthesis, glucose is α -linked to the phenolic hydroxy group of a tyrosine residue [36] and galactosyl( β 1-O)tyrosine has been identified in glycoproteins of the crystalline surface layers ( S -layers) of eubacteria [37, 38] . In the collagens, β -galactose is linked to hydroxylysine [39, 40] . Hydroxyproline, finally, is glycosylated with β -L -arabinofuranose in certain plant glycoproteins [41, 42, 43] and with α -galactose in plants and eubacteria.
GPI Anchors
Glycosylphosphatidylinositol (GPI) anchors provide a means for anchoring proteins with a wide variety of structures and functions to the external surface of the plasma membrane of eukaryotic cells. The existence of lipid anchors for membrane proteins was initially demonstrated by the ability of phosphatidylinositol-specific phospholipase C (PI-PLC) to release alkaline phosphatase from 
Scheme 3. Carbohydrate-peptide linkages found in O-glycoproteins
various mammalian tissues into the medium [44, 45] . Later, it was observed that fatty acids and ethanolamine were attached to the carboxy terminus of the rat Thy-1 antigen which provided direct evidence for a glycolipid anchor being covalently attached to protein [46] . In 1985 these and other results were combined to establish a common mode of membrane attachment via a GPI anchor covalently bound to the C-terminus through ethanolamine [47] . Today, we know well over 100 proteins which are GPI-anchored (reviewed in [48, 49, 50, 51, 52, 53, 54] ) and the structures of several GPI anchors have been elucidated, the first being that on the Trypanosoma brucei variant surface glycoprotein (VSG) [55, 56] . All characterized GPI anchors share a common core of ethanolamine-PO 4 -6Man( α 1-2)Man( α1-6)Man(α1-4)GlcN(α1-6)myo-Ino-1-PO 4 -lipid. This may be further processed in a cell-type and protein-specific manner (Scheme 4). The rat brain Thy-1 anchor, for example, contains additional Man(α1-2) and GalNAc(β1-4) residues, whereas the tetrasaccharide backbone of the trypanosome VSG anchor is modified with a branched chain of α-linked galactoses. In human erythrocyte acetylcholinesterase [57] and decay accelerating factor [58] the first and second mannoses carry additional phosphoethanolamines. Attached to the phosphoinositol are lipids of varying chain length and saturation including diacylglycerol, alkyl-acylglycerol, stearoyl-lysoglycerol, or ceramide. In the VSG anchor, for example, dimyristylglycerol has been identified. Furthermore, the inositol may be acylated with an additional fatty acid, most commonly palmitoyl, presumably at positions 2 or 3 of the inositol ring [59] . Diacylglycerol Alkyl-acylglycerol Ceramide
Scheme 4. Minimal structure and some modifications of GPI anchors
Biosynthesis of GPI anchors starts with the core structure assembly by sequential addition of UDP-GlcNAc (followed by N-deacetylation), dolichol-phosphate-mannose, and phosphoethanolamine to phosphatidylinositol and culminates in the en bloc transfer to protein shortly after the protein is synthesized. However, the biosynthetic pathways can differ strikingly between different organisms with respect to specific modifications and fatty acid remodeling occurring after completion of the core glycan. This also applies for the point when certain modifications are introduced, e.g., before or after the transfer of the GPImoiety to the protein.
GPI anchors can be cleaved at defined positions by an array of enzymatic and chemical methods, respectively (Scheme 5). Thus, it becomes possible to identify GPI-anchored proteins and, moreover, analyze the structure and biosynthesis of GPI anchors [60] .
The most obvious function of GPI anchors is to provide a stable, oriented attachment of proteins onto membranes, usually the extracellular surface of plasma membranes. However, there is much discussion over whether this highly conserved, multiple-step, complex mechanism for anchoring proteins has additional functions and it has been proposed that GPI anchors -increase the lateral mobility of proteins, -mediate the release or secretion of proteins, -target proteins to apical surfaces, -mediate endocytosis or protein turnover, and -participate in transmembrane signaling mechanisms [54] .
Scheme 5. Enzymatic and chemical cleavage sites of GPI anchors most commonly used for the identification and structural analysis of GPI anchors. In addition, all phosphoric esters are cleavable by aqueous hydrofluoric acid. GPI-PLC*, GPI-specific phospholipase C; GPI-PLD, GPI-specific phospholipase D; PI-PLC*, phosphatidyinositol-specific phospholipase C. *: Cleaves only if the inositol is unmodified
Uncommon Linkages
In 1994 a previously unknown type of carbohydrate-protein linkage was identified in human Rnase U s with a mannose residue α-C-glycosidically attached to the indole ring of Trp-7 as a result of a post-translational modification (Scheme 6) [61, 62, 63] . Another uncommon linkage has been characterized in the lysosomal proteinase I of Dictyostelium discoideum in which β-N-acetylglucosamine is bound to the side-chain hydroxy group of serine via a phosphodiester bridge [64] .
Methods of Glycoprotein Analysis
Structural analysis of glycans contained in glycoproteins [65, 66] is a challenging task due to the lack of a general oligosaccharide sequencing method like those available for peptides or oligonucleotides. The situation is further complicated by the phenomenon of microheterogeneity which makes only minute amounts of homogenous material available. Fractionation of individual glycoforms of a given glycoprotein can be achieved using capillary electrophoresis but is not generally applicable because the differences in physicochemical properties between neutral glycoforms are often relatively small. Therefore, protein glycosylation analysis is usually carried out after release of the glycans either from the whole glycoprotein or from glycopeptides obtained by proteolytic digestion 
Release of Glycans from Glycoprotein
In order to release glycans from a glycoprotein a general method is required that is independent of the protein to which the saccharides are attached. In this respect, chemical release is often preferred over the use of endoglycosidases or glycoamidases. Hydrazinolysis [67] has initially been described for release of Nglycans (Scheme 7) but later on it was shown that, under controlled conditions, the method is also suitable for O-glycans [68] enabling its application in an automated apparatus (GlycoPrep from Oxford GlycoSystems). As long as a reducing saccharide is not required at the cleavage point, O-glycans can be more mildly released in the form of oligosaccharide alditols by treatment with alkaline borohydride [69] . Enzymatic release [70] of N-glycans is most frequently effected by the peptide N-glycanases (PNGases) F or A which, under denaturing conditions, generally cleave the Cγ-Nδ bond of glycosylated asparagines releasing the intact N-linked glycans. Alternatively, endoglycosidase H (Endo H) or D (Endo D) can be applied which cleave between the first and second N-acetylglucosamine residues attached to asparagine. Enzymatic release of O-glycans is much more difficult since most O-glycanases currently available are highly specific. Therefore, after PNGase treatment of N,O-glycoproteins, the remaining O-linked glycans are often released by alkaline borohydride degradation.
Labeling and Separation of Glycans
Unless mass spectrometric analysis of the glycan pool is carried out, the released sugars need to be tagged to enable them to be detected. Classically, the reducing end of the oligosaccharides is reduced with alkaline sodium borotritide [71] . Today, radioactive labeling has been largely replaced by reductive amination with fluorescent compounds like 2-aminobenzamide [72] are compatible with a range of separation techniques including HPLC (normal phase, reversed phase, and weak anion exchange), high pH anion exchange chromatography (HPAEC), lectin-affinity chromatography, polyacrylamide gel electrophoresis (PAGE), capillary electrophoresis (CE), and gel permeation chromatography (GPC).
Sequencing of Glycans
For complete structural analysis of oligosaccharides, a combination of several physical, chemical, and biochemical techniques including NMR spectroscopy, mass spectrometry, and chemical and enzymatic degradation is required. Enzymatic analysis using highly specific exoglycosidases is a powerful means of determining the sequence of glycans especially if only very small amounts of material (picomoles or less) are available. This method is based on the determination of the susceptibility of a glycan to a series of exoglycosidases of defined specificity. In the case of the reagent array analysis method (RAAM) [77] , the process has been automated (GlycoPrep from Oxford GlycoSystems). The glycan is divided into several aliquots and each aliquot is incubated with a defined mixture of exoglycosidases called a reagent array. Degradation occurs in each vial until a linkage is reached which is resistant to all exoglycosidases present in that mix. The remaining "stop point" fragments containing the labeled reducing end saccharides are characterized by size (GPC). From these data, a computer program constructs the sequence of the glycan. Recently, an improved approach has been developed involving the simultaneous digestion of aliquots of a total pool of fluorescently labeled oligosaccharides with a series of multiple enzyme arrays [78] .
Structure of N-Glycans
Due to their biosynthesis, all N-glycoproteins share the common core pentasaccharide Man(α1-6)[Man(α1-3)]Man(β1-4)GlcNAc(β1-4)GlcNAc. The tremendous diversity of asparagine-linked oligosaccharides derives from attachment of several monosaccharides as well as up to five different carbohydrate chains, the so-called antennae, to the core. On the basis of the structure and the location of the glycans attached to the trimannosyl core, N-glycoproteins can be classified into four main groups. These are -oligomannose (high mannose), -complex, -hybrid, and -the recently added [10] xylose-containing type (Scheme 8).
Oligomannose-type glycans usually contain two to six α-mannose residues bound to the core. The largest high mannose oligosaccharide thus contains nine mannose and two N-acetylglucosamine residues which were originally discovered in bovine thyroglobulin [79] . High molecular mass oligomannose chains with up to 100-200 mannose residues are, however, produced by yeasts. Complex-type glycans contain no mannose residues other than those in the core. To the outer two α-mannose residues up to five units of the disaccharide Gal(β1-4)GlcNAc (N-acetyllactosamine) are β-linked. In the bi-, tri-, and tetraanten-
Xylose-containing
Scheme 8. Examples of the four main types of N-linked oligosaccharides of glycoproteins. The structure within the gray box represents the pentasaccharide core common to all N-glycans nary glycans, these branches are attached to specific positions of the core as indicated in Scheme 8.
The N-acetyllactosamine units are frequently substituted with sialic acid residues or additional repeats of N-acetyllactosamine, resulting in so-called poly-N-acetyllactosamines which themselves are capped by sialic acids. Further diversification can be achieved by attachment of α1-6 linked fucose to the most inner core N-acetylglucosamine residue and of an N-acetylglucosamine residue linked β1-4 to the β-mannose of the core ("bisecting" GlcNAc). In addition, various monosaccharides can be found in the antennae.
Oligosaccharides of the hybrid type have characteristic features of both complex-type and oligomannose-type glycans. One or two mannose residues are α-linked to the Man(α1-6) branch of the core pentasaccharide and one or two antennae like those found in complex-type oligosaccharides are β-linked to the Man(α1-3) branch of the core. This type of glycan results from partial processing of oligomannose-type glycans produced during biosynthesis and subsequent addition of sugars. The fourth group of N-glycans is named xylose-containing and is characterized by a xylose residue linked β1-2 to the β-mannose of the core. Often, there is also fucose α1-3 linked to the innermost N-acetylglucosamine of the core.
Diversity of N-Glycans
As mentioned earlier, the structural diversity of glycans is provided by the variation of monosaccharides attached to the core, the degree of branching (antennary), and, particularly, the tremendous variation in the structures of the antennae. Some side chains commonly occurring in complex N-glycans are depicted in Scheme 9. These structures can be roughly classified into five groups. The first group is represented by N-acetyllactosamine which is the starting point for further modification but is still frequently found intact. Group two consists of side chains terminated by sialic acid, fucose, or galactose. Once these modifications have taken place, no further chain elongation is possible except for formation of polysialic acids. Following sialylation it is also still possible to transfer fucose or sialic acid to the N-acetylglucosamine residues, resulting in some of the structures of group three, e.g., Neu5Ac(α2
On the other hand, fucosylation of a subterminal N-acetylglucosamine residue halts the chain elongation in a non-sialylated, fucosylated form. Group four consists of long-chain structures containing either linear or branched poly-N-acetyllactosamine or α2-8 linked sialic acid repeatedly added to α2-3 linked sialic acid, forming polysialyl side chains. Group five side chains contain N-acetylgalactosamine instead of galactose. These structures may be further modified by sialylation or sulfation. There are many more variations in N-glycan chains identified to date [1, 8] and many more are expected to be found in future studies.
Gal(β1-4)GlcNAcβ1→
Fuc(α1-3)
Group 1

Gal(β1-3)GlcNAcβ1→
Neu5Ac(α2-3)GalNAc(β1-4)GlcNAcβ1→
Neu5Ac(α2-6)Gal(β1-4)GlcNAcβ1→
Neu5Ac(α2-3)Gal(β1-4)GlcNAcβ1→
Group 4
Group 5 Scheme 9. Commonly occurring structures of complex-type N-glycan side chains. The arrows indicate the point of attachment to the pentasaccharide core
Cell-Type Specific Expression of N-Glycans
As described above, the enormous diversity of N-glycans is largely provided by variation of structures in the antennae. However, expression of specific carbohydrate epitopes, so-called antigenic determinants, is highly controlled and often cell-type specific. Critical findings revealed that poly-N-acetyllactosamines which are contained in many complex-type N-glycoproteins (but also in O-glycoproteins and glycolipids) provide a preferable backbone for many of the celltype specific glycosylations, such as the ABH(O), I/i, and Lewis (Le a , Le x , and sialylated forms thereof) blood group and differentiation antigenic determinants [80] . Poly-N-acetyllactosamine repeats are not uniformly distributed among different antennae attached to the trimannosyl core. Due to the branch specificity of β1-3-N-acetylglucosaminyltransferase -the key enzyme for formation and elongation of poly-N-acetyllactosamine chains -poly-N-acetyllactosamine extensions are more common at the α1-6 linked mannose of the core. Tetraantennary glycans are particularly good acceptor substrates for poly-N-acetyllactosamine chain formation. Termination of chain elongation by sialylation leads to structures summarized in Scheme 10. Glycosylation patterns of glycoproteins (and glycolipids) in human erythrocytes and granulocytes are well established examples for cell-type specific expression of glycans. Some important carbohydrate antigenic determinants are listed in Table 2 .
Erythrocytes and granulocytes directly differentiate from the same precursor stem cells. In fetal erythrocytes, poly-N-acetyllactosamine is linear and expresses blood type i activity. In adult erythrocytes, poly-N-acetyllactosamines are branched at galactose, forming Gal(β1-4)GlcNAc(β1-3)[Gal(β1-4)GlcNAc(β1-6)]Gal(β1-4)GlcNAc, the blood group I antigen. The change from i to I specificity occurs gradually during the first year of life. Terminal galactose residues of the branched poly-N-acetyllactosamine chains of erythrocytes are then modified by α1-2 linked fucose, forming the H antigen. This reaction is catalyzed by an α1-2-fucosyltransferase.
Scheme 10. Representative structures of tetraantennary poly-N-acetyllactosamine containing N-glycans based on structures reported in various cells. The length of the N-acetyllactosamine repeats generally decreases in the order m>n>o. Sialic acids attached to poly-N-acetyllactosamine chains are usually α2-3 linked whereas α2-6 sialylation preferentially occurs at the side chain linked β1-2 to the Man(α1-3) branch of the core [a] Type 1 contains the sequence Gal(β1-3)GlcNAc, type 2 contains the sequence Gal(β1-4)GlcNAc.
The H structure, Fuc(α1-2)Gal(β1-3/4)GlcNAc, is present in O-type blood group individuals. This structure now serves as acceptor for α1-3-N-acetylgalactosaminyltransferase or α1-3-galactosyltransferase, forming A and B blood group antigens, respectively.
In granulocytes, no branching of poly-N-acetyllactosamines is observed. α1-3-Fucosyltransferase-catalyzed modification of the linear chains leads to the Lewis x antigen. If α2-3-sialyltransferase acts before fucosylation, sialyl Lewis x is formed. These carbohydrate structures are involved in a number of cell-cell interactions during the inflammatory response and malignant transformations [81] . Production of Lewis x and sialyl Lewis x is restricted to the myeloid cell lineage and only granulocytes and monocytes are enriched with them in blood cells. In contrast, expression of the ABH blood group antigens is restricted to erythroid cells, and no other blood cells contain ABH blood group antigens. This cell-type specific expression of glycans is caused by the presence of certain key glycosyltransferases which are essential for the formation of the corresponding carbohydrate structures and of which expression is restricted to that particular cell type.
Structure of O-Glycans
The biosynthesis of O-glycans differs fundamentally from that of the N-glycans. O-Glycosylation does not begin with the transfer of an oligosaccharide from a dolichol precursor to the nascent peptide chain which is then further processed. Instead, O-glycosylation is mainly a post-translational and post-folding event and is initiated by glycosyltransferase-catalyzed addition of a single monosac- 83, 84] . Subsequent stepwise enzymatic elongation of the monoglycosylated polypeptide then leads to several core structures, eight of which have been identified to date (Scheme 11). However, under certain circumstances (e.g., in particular transformed cells), elongation does not occur and the Tn antigen is exposed which might be modified to sialyl Tn (sTn) (Neu5Ac(α2-6)GalNAc(α1-O)Ser/Thr) [85, 86] . Depending on the cell type and its activation and differentiation status, the core structures can be further elongated or terminated by various glycosyltrans-ferases, resulting in a large number of O-glycans, of which some are depicted in Scheme 12. Many of these glycosyltransferases have been isolated and their genes have been cloned [87, 88] . There are glycosyltransferases which specifically act on O-glycans (mainly those responsible for assembly of the core structures) and there are others with an activity restricted to N-glycans. However, a third group is able to assemble both N-and O-glycans. The antigenic determinants mentioned in Sect. 2.4.2 are generated by such transferases, i.e., the structures listed in Table 2 O-glycans are often elongated by N-acetyllactosamine, which is a substrate for conversion into the type 2 antigenic determinants sLe x , Le x , H type 2, Le y , A type 2, and B type 2. Core 1 is, however, a poor acceptor for poly-N-acetyllactosamine formation. To efficiently achieve this type of extension, core 1 first has to be transformed into core 2. Then, poly-N-acetyllactosamine formation can take place at the new GlcNAc(β1-6) branch. Thus, the expression of core 2 Nacetylglucosaminyltransferase (core 2 GlcNAcT), the enzyme responsible for the conversion of core 1 into core 2, is rate limiting for the biosynthesis of poly-Nacetyllactosamine extensions. The fact that poly-N-acetyllactosamine extensions provide an excellent backbone for the expression of antigenic determi-
GlcNAc(β1-6)
Core 5
GlcNAc(β1-3) 
Poly-N-acetyllactosamine extension: nants involved in numerous recognition events highlights the biological importance of core 2 GlcNAcT. So far, core 3 and 4 have been found only in mucins. Core 5 is contained in glycoproteins from several species and has been reported in human adenocarcinoma [89] and meconium [90] . To date, core 6 has only been found in human glycoproteins. It has been speculated that core 6 might be generated by a β-galactosidase-catalyzed degradation of core 2 [87] . Core 7 occurs in bovine submaxillary mucin [91] and up to now has been found only as the disaccharide. All other core structures may be unsubstituted or elongated and may carry terminal antigens. Elongation can result in type 1 chains [containing the sequence Gal(β1-3)GlcNAc] or type 2 chains [containing the sequence Gal(β1-4)GlcNAc, e.g., i antigen, poly-N-acetyllactosamines] and branched structures (I antigen). Neu5Ac(α2-3 and -6), Fuc(α1-2, -3, and -4), GalNAc(α1-3 and -6), GalNAc(β1-4), GlcNAc(α1-4), Gal(α1-3), and sulfated residues are typically found as terminal structures on O-glycans although sialic acids, sulfate, and Fuc(α1-3 or -4) may be also attached to internal carbohydrate residues. Many of the terminal structures are of the Lewis and ABH blood group system (Table 2 ) and are also found on N-glycoproteins and glycolipids.
Non-Mucin O-Glycans
Beside the GalNAc(α1-O)Ser/Thr linkage of the mucin-type O-glycans, a number of additional O-linkages has been identified. These include mainly fucose α-O-linked to Ser/Thr and glucose β-O-linked to Ser found in the epidermal growth factor (EGF) domains of different proteins [29] and N-acetylglucosamine β-O-linked to Ser/Thr on cytoplasmic and nuclear proteins.
O-Linked fucose has been found on the EGF domains of urokinase, tissue plasminogen activator (tPA), factor VII, and factor XII, attached to the consensus sequence Cys-Xaa-Xaa-Gly-Gly-Ser/Thr-Cys. The fucosyltransferase responsible for the initiation of this type of glycosylation has been cloned [92] . On human (but not bovine) factor IX the tetrasaccharide Neu5Ac(α2-6)Gal(β1-4)GlcNAc(β1-3)Fuc(α1-O)Ser (Scheme 13, structure a) was found [93, 94] . In other EGF domains only Fuc(α1-O)Ser/Thr was detected.
On the same EGF modules glucose β-O-linked to the Ser of the conserved consensus sequence Cys-Xaa-Ser-Xaa-Pro-Cys occurs. In several proteins like the human and bovine blood clotting factors VII and IX, human and bovine protein Z, tPA, thrombospondin, and murine fetal antigen 1 (mFA1) Xyl(α1-3)Xyl(α1-3)Glc(β1-O)Ser (Scheme 13, structure b) and substructures thereof [Xyl(α1-3)Glc(β1-O)Ser and Glc(β1-O)Ser] have been identified. The transferase activity responsible for addition of the second xylose has been detected [95] .
The N-acetylglucosaminyl(β1-O)serine/threonine linkage is common on cytoplasmic and nuclear proteins [27, 28] . No other sugars are connected to the GlcNAc residue. Formation of this type of modification is independent of the ac-tivity of the glycosylation machinery in the endoplasmic reticulum and the Golgi apparatus. Addition of O-GlcNAc is catalyzed by a highly conserved O-GlcNAc transferase cloned independently by two groups [96, 97] . The specificity of this enzyme resembles that of proline-directed kinases. O-GlcNAc is found in serine/threonine-rich sequences near Pro and Val residues. Often a negative charge is located nearby. Since the turnover of the O-GlcNAc glycan is faster than that of the peptide to which the sugar is attached, O-GlcNAc glycosylation is assumed to be reversible. Further evidence for this is the existence of a soluble N-acetyl-β-D-glucosaminidase [98] . It is likely that O-GlcNAc glycosylation plays a regulatory role that is analogous to protein phosphorylation.
The mannosyl(α1-O)Ser/Thr linkage is uncommon in mammalian cells. In bovine peripheral nerve α-dystroglycan clusters of Neu5Ac(α2-3)Gal(β1-4)GlcNAc(β1-2)Man(α1-O)Ser/Thr (Scheme 13, structure c) have been observed in Ser/Thr-rich domains [33] . A similar glycan [Neu5Ac(α2-3)Gal(β1-4)GlcNAc(β1-3)Man(α1-O)Ser/Thr] has been found in rat brain proteoglycans [34, 35] . 
Proteoglycans
Proteoglycans [99] consist of glycosaminoglycan chains covalently attached to a protein backbone. Therefore, they can be classified as glycoproteins. However, for historical reasons and because they differ substantially from other glycoproteins, they are usually treated as a separate class of compounds. Glycosaminoglycans are linear polysaccharides consisting of hexosamine residues like N-sulfonylglucosamine (GlcNS), N-acetylglucosamine (GlcNAc), or N-acetylgalactosamine (GalNAc) alternating with glucuronic acid (GlcA) or L-iduronic acid (IdoA) or galactose (Gal) residues. Different types of glycosaminoglycans are characterized by specific disaccharide repeat patterns. These oligosaccharides are substituted to varying degrees with sulfate linked to free amino and/or hydroxy groups and range in size from ca. 15 disaccharide units to several hundred. The glycosaminoglycans contained in proteoglycans are chondroitin sulfate, dermatan sulfate, heparan sulfate, heparin, and keratan sulfate. Usually one type of glycosaminoglycan predominates but hybrid proteoglycans do exist. Another glycosaminoglycan (hyaluronan or hyaluronic acid) is not covalently attached to protein. A striking feature of all glycosaminoglycans is their negative charge caused by their sulfate and carboxyl groups which distinguishes these molecules from other glycoproteins. In addition to the glycosaminoglycan chains some proteoglycans contain O-and N-linked oligosaccharides similar or identical to those of various classes of glycoproteins.
Proteoglycans are widely distributed in the animal and plant kingdoms and they possess both structural and regulatory roles [100, 101] . They are found in the extracellular matrix (ECM) and associated with specialized structures of the ECM like basement membranes. They also occur as part of plasma membranes where they function as receptors and co-receptors, and they are found intracellularly and intravesicularly in many hematopoietic cells. Many diseases like chondrodystrophies [102] , atherosclerosis [103] , different types of cancer [104] , or Alzheimer's disease [105] are related to abnormalities in the biosynthesis and processing of proteoglycans [99a].
Carbohydrate-Peptide Linkage Region
Chondroitin sulfate, dermatan sulfate, heparan sulfate, and heparin are linked with their reducing end to the common core tetrasaccharide GlcA(β1-3)Gal(β1-3)Gal(β1-4)Xyl with the Xyl β-O-linked to a Ser residue (Scheme 14), usually adjacent to a Gly in the protein backbone [99] . The GlcA residue of this tetrasaccharide is considered as part of the linkage region because the transferase involved in the addition of this residue to the Gal-Gal disaccharide is different from the enzyme that catalyzes the incorporation of GlcA into the rest of the glycosaminoglycan. The xylose may be phosphorylated and one or both galactose residues may be sulfated.
Skeletal keratan sulfate and corneal keratan sulfate are linked to core protein through O-linked and N-linked oligosaccharides, respectively, of the general types described in Sects. 2.4 and 2.5.
Structure of Glycosaminoglycans
Hyaluronan (hyaluronic acid) is the simplest glycosaminoglycan. It consists of alternating GlcA and GlcNAc residues that are (β1-3) and (β1-4) linked, respectively (Scheme 15) [99] . Hyaluronan is not sulfated and is not bound to protein, thus it is not a component of proteoglycans.
Chondroitin sulfate glycosaminoglycans are composed of the disaccharide repeat unit GlcA(β1-3)GalNAc(β1-4) with variable amounts of sulfation at the positions indicated in Scheme 15. Dermatan sulfate is formed from the precursor chondroitin sulfate by the action of an appropriate uronosyl epimerase which converts GlcA into IdoA, giving rise to the disaccharide repeat unit IdoA(α1-3)GalNAc(β1-4) [106] . Thus, both glycosaminoglycans are found on the same protein core. However, there is still no unambiguous convention about what the proportion of IdoA must be to name a glycosaminoglycan dermatan sulfate. Ordinarily, IdoA is only formed adjacent to 4-sulfated GalNAc and not adjacent to 6-sulfated or non-sulfated GalNAc.
Heparan sulfate glycosaminoglycans and heparin are more complex. They contain two main types of disaccharide residue, although the proportions differ greatly between heparan sulfate and heparin. Heparan sulfate consists of areas of non-sulfated GlcA(β1-4)GlcNAc(α1-4) and areas of sulfated IdoA(α1-4)Glc-NS(α1-4) disaccharide repeat units with the latter being obtained from the former by the action of modifying enzymes during biosynthesis. Heparin differs from heparan sulfate by its higher content of IdoA, N-sulfate, and O-sulfate with most of the disaccharide units containing 2-sulfated IdoA alternating with Glc-NS which is partially 6-sulfated and occasionally 3-sulfated as well. On some heparan sulfates occasional 3-sulfation of GlcNS is also found. Although heparan sulfate and heparin are structurally similar one should keep in mind that both are found on different core proteins.
Keratan sulfate glycosaminoglycans are sulfated poly-N-acetyllactosamines of the type found in N-and O-glycoproteins. The degree of sulfation which takes place at the primary hydroxy groups is variable along the oligosaccharide chains with a higher degree at the non-reducing end.
Peptidoglycan
Peptidoglycan (synonym: murein) [107, 108] is the essential cell wall polymer of most eubacteria, both Gram-positive and Gram-negative. Although it is not regarded as a glycopeptide it will be briefly treated in this chapter since it consists of carbohydrates covalently attached to peptides. Furthermore, knowledge of peptidoglycan structure is helpful for an understanding of the mode of action of the glycopeptide antibiotics of the vancomycin group.
Peptidoglycan is composed of three structural features: a matrix of polysaccharide chains, the pentapeptide side chains, and the interstrand peptide crosslinks, called interpeptide bridges (Scheme 16, structure a). The glycan component of all peptidoglycans consists of alternating β1-4 linked GlcNAc and Nacetylmuramic acid (MurNAc) (a GlcNAc with a lactyl ether at O3) residues, ranging in size from ca. 5 to 45 disaccharide units [109] . This structure is common to all bacterial peptidoglycans examined, with only minor variations. In Staphylococcus aureus, for example, up to 50% of the MurNAc residues are 6-Oacetylated [110] and in Micrococcus lysodeikticus up to 40% of the MurNAc residues are not attached to peptide chains [111] .
Attached to the carboxylate of MurNAc is a pentapeptide with the common sequence Ala-γ-D-Glu-Xaa-D-Ala-D-Ala (non-specification of the amino acid configuration implies the natural L-form), where Xaa is meso-diaminopimelic acid (m-DAP) for Gram-negative bacteria and Lys for most Gram-positive bacteria, with some variations [112] . During peptidoglycan biosynthesis the pentapeptide is cross-linked through amino acid Xaa to another peptide strand. Peptidoglycan strands are connected to varying degrees by a network of cross-links formed between the pentapeptide side chains. The structures of these cross-links, which are quite heterogeneous, have been reviewed [107, 109, 112] and this feature has been used for taxonomic classification of bacteria [112] . Here only two examples are presented (Scheme 17). In Escherichia coli and strains of Bacillus the simplest type of linkage is realized, i.e., the direct attachment of the ε-amino group of m-DAP to D-Ala at position 4 of the second peptide. If L-lysine is found in position 3 of the peptide chain, which is the case for most Gram-positive bacteria, usually 1-5 amino acid residues (L-configurated or glycine) are incorporated between the ε-amino function of Lys and the DAla of the second peptide. As such, the interpeptide bridge of the well-studied Staphylococcus aureus Copenhagen strain consists of pentaglycine. However, other strains of Staphylococcus contain Ala, Ser, or Thr.
Glycopeptide Antibiotics
Discovery and Medical Use
Vancomycin was discovered in the mid-1950s in a soil sample from the jungles of Borneo by coworkers of the American pharmaceutical company Eli Lilly [113] . It is produced as a secondary metabolite by a microorganism (now) called Amycolatopsis orientalis [114] and displays antibiotic activity against the majority of Gram-positive bacteria. The discovery of vancomycin was followed a year later by the isolation of ristocetin [115] . These two antibiotics were recognized as belonging to a chemical class of antibiotics called glycopeptides [116, 117, 118] . Vancomycin was first used clinically in 1959. However, toxicity problems due to inadequacies during its purification precluded its widespread use in the early years and vancomycin was for the moment overshadowed by semisynthetic penicillins and later cephalosporins. However, with improved purification techniques and as the result of the emergence of multiple-resistant and methicillinresistant strains of Staphylococcus aureus (MRSA) vancomycin has become the drug of choice in the fight against these "superbugs" [117a] . Ristocetin appeared to be a promising antibacterial agent in the late 1950s but it was withdrawn following the death of several patients [119] . Avoparcin has shown growth-promoting activity in farm animals and has been marketed in Europe since 1976 as a feed additive. It is also used in the dairy industry for improvement of milk production of lactating dairy cows. Today two members of the group of the glycopeptide antibiotics are in clinical use -vancomycin and teicoplanin. Together with the aminoglycoside gentamycin, they are the antibiotics of last resort in our hospitals. However, first signs of vancomycin resistant S. aureus strains are now being observed [120].
Structure and Classification
The first structural work on vancomycin were degradation studies carried out by Marshall [121] followed by extensive NMR examinations in the laboratory of Williams [122] . Based on these pioneering studies and on the X-ray analysis of the degradation product CDP-1 [123] , Harris and Harris published the complete structure of vancomycin in 1982 [124] . The determination of the vancomycin structure then served as basis for the structural characterization of hundreds of natural and semisynthetic glycopeptide antibiotics.
The glycopeptide antibiotics consist of a peptide backbone of 7 amino acids (see Scheme 18 for selected examples). The side chains of amino acids 2 and 4 as well as 4 and 6 and in most cases also 5 and 7 are linked to each other, either via biaryl ether or direct biaryl bonds. The resulting structural elements give rise to the phenomenon of atropisomerism. Bound to this peptide core are 1-4 saccharides (mono-to tetrasaccharides). Glycopeptide antibiotics can be subdivided in four or five groups based on their chemical structures [118, 125] . Group I, or the vancomycin type, has aliphatic amino acids at positions 1 and 3 while groups II-IV, illustrated by avoparcin, ristocetin, and teicoplanin, respectively, are characterized by aromatic residues at these positions. Members of groups III and IV have an additional biaryl ether bridge between the side chains of amino acids 1 and 3. Type IV glycopeptide antibiotics could be considered a subgroup of III since the arrangement of the amino acids in the peptide core is the same. The antibiotics of this group have a fatty acid residue attached to an Scheme 18. Selected structures of glycopeptide antibiotics belonging to groups I-IV amino sugar. Finally, a fifth type of antibiotics can be defined containing a characteristic tryptophan residue at position 2. However, the members of this group identified so far (chloropeptin I, complestatin, and kistamycins A and B) are not glycosylated.
Recently, total syntheses of vancomycin [126] and its aglycone [127] have been accomplished by several research groups.
